Real-world outcomes associated with letermovir use for cytomegalovirus (CMV) primary prophylaxis in allogeneic-hematopoietic cell transplant recipients: a systematic review and meta-analysis of observational studies

被引：0
|
作者：
Raval, A. [1 ]
Kamat, S. [2 ]
Vyas, A. [2 ]
Tang, Y. [1 ]
LaPlante, K. [2 ]
Chemaly, R. [3 ]
机构：
[1] Merck & Co Inc, Kenilworth, NJ USA
[2] Univ Rhode Isl, Kingston, RI 02881 USA
[3] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
来源：
BONE MARROW TRANSPLANTATION | 2022年 / 57卷 / SUPPL 1期
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
O089
引用
收藏
页码：59 / 60
页数：2
相关论文
共 50 条
  • [21] The Association Between Cytomegalovirus And Invasive Fungal Infections in Allogeneic Hematopoietic Stem Cell Transplant Recipients: A Systematic Review And Meta-Analysis
    Chuleerarux, Nipat
    Thongkam, Achitpol
    Nematollahi, Saman
    Dioverti-Prono, Veronica
    Manothummetha, Kasama
    Torvorapanit, Pattama
    Langsiri, Nattapong
    Worasilchai, Navaporn
    Plongla, Rongpong
    Chindamporn, Ariya
    Sanguankeo, Anawin
    Permpalung, Nitipong
    BONE MARROW TRANSPLANTATION, 2021, 56 (SUPPL 1) : 108 - 109
  • [22] A Real-World Efficacy of Letermovir Primary Prophylaxis for Cytomegalovirus Infection after Allogeneic Hematopoietic Stem Cell Transplantation in China: A Single-Center Retrospective Analysis
    Zhang, Xiaoyu
    Yang, Donglin
    Pang, Aiming
    He, Yi
    Wei, Jialin
    Zhang, Rongli
    Zhai, Weihua
    Ma, Qiaoling
    Chen, Xin
    Han, Mingzhe
    Feng, Sizhou
    Jiang, Erlie
    BLOOD, 2023, 142
  • [23] Letermovir prophylaxis for cytomegalovirus in lung-transplant recipients: a comprehensive study with literature review of off-label use and real-world experiences
    Hirama, Takashi
    Shundo, Yuki
    Watanabe, Toshikazu
    Ohsumi, Akihiro
    Watanabe, Tatsuaki
    Okada, Yoshinori
    CLINICAL AND EXPERIMENTAL MEDICINE, 2024, 24 (01)
  • [24] Systematic review and mixed treatment comparison meta-analysis of randomized clinical trials of primary oral antifungal prophylaxis in allogeneic hematopoietic cell transplant recipients
    Bow, Eric J.
    Vanness, David J.
    Slavin, Monica
    Cordonnier, Catherine
    Cornely, Oliver A.
    Marks, David I.
    Pagliuca, Antonio
    Solano, Carlos
    Cragin, Lael
    Shaul, Alissa J.
    Sorensen, Sonja
    Chambers, Richard
    Kantecki, Michal
    Weinstein, David
    Schlamm, Haran
    BMC INFECTIOUS DISEASES, 2015, 15
  • [25] Systematic review and mixed treatment comparison meta-analysis of randomized clinical trials of primary oral antifungal prophylaxis in allogeneic hematopoietic cell transplant recipients
    Eric J Bow
    David J Vanness
    Monica Slavin
    Catherine Cordonnier
    Oliver A Cornely
    David I Marks
    Antonio Pagliuca
    Carlos Solano
    Lael Cragin
    Alissa J Shaul
    Sonja Sorensen
    Richard Chambers
    Michal Kantecki
    David Weinstein
    Haran Schlamm
    BMC Infectious Diseases, 15
  • [26] Real-world efficacy of letermovir prophylaxis for cytomegalovirus infection after allogeneic hematopoietic stem cell transplantation: A single-center retrospective analysis
    Yoshimura, Hideaki
    Satake, Atsushi
    Ishii, Yuka
    Ichikawa, Jun
    Saito, Ryo
    Konishi, Akiko
    Hotta, Masaaki
    Nakanishi, Takahisa
    Fujita, Shinya
    Ito, Tomoki
    Ishii, Kazuyoshi
    Nomura, Shosaku
    JOURNAL OF INFECTION AND CHEMOTHERAPY, 2022, 28 (09) : 1317 - 1323
  • [27] Risk factors associated with the development of clinically significant cytomegalovirus (CMV) infection in the allogeneic hematopoietic-cell transplant (HCT) letermovir prophylaxis trial
    Marty, Francisco M.
    Ellison, Misoo C.
    Rabitsch, Werner
    Itala-Remes, Maija
    Dominietto, Alida
    Peggs, Karl
    Browett, Peter
    Moreno, Mariela
    Leavitt, Randi Y.
    Joshi, Amita
    Badshah, Cyrus
    Yeh, Wendy W.
    BONE MARROW TRANSPLANTATION, 2019, 54 : 101 - 102
  • [28] Real-Life Data on the Efficacy and Safety of Letermovir for Primary Prophylaxis of Cytomegalovirus in Allogeneic Hematopoietic Stem Cell Recipients: A Single-Center Analysis
    Wlodarczyk, Martyna
    Wieczorkiewicz-Kabut, Agata
    Bialas, Krzysztof
    Koclega, Anna
    Noster, Izabela
    Zielinska, Patrycja
    Helbig, Grzegorz
    TURKISH JOURNAL OF HEMATOLOGY, 2024, 41 (01) : 9 - 15
  • [29] Letermovir prophylaxis is effective in preventing cytomegalovirus reactivation after allogeneic hematopoietic cell transplantation: single-center real-world data
    Patrick Derigs
    Aleksandar Radujkovic
    Maria-Luisa Schubert
    Paul Schnitzler
    Tilman Schöning
    Carsten Müller-Tidow
    Ute Hegenbart
    Stefan O. Schönland
    Thomas Luft
    Peter Dreger
    Michael Schmitt
    Annals of Hematology, 2021, 100 : 2087 - 2093
  • [30] Letermovir prophylaxis is effective in preventing cytomegalovirus reactivation after allogeneic hematopoietic cell transplantation: single-center real-world data
    Derigs, Patrick
    Radujkovic, Aleksandar
    Schubert, Maria-Luisa
    Schnitzler, Paul
    Schoening, Tilman
    Mueller-Tidow, Carsten
    Hegenbart, Ute
    Schoenland, Stefan O.
    Luft, Thomas
    Dreger, Peter
    Schmitt, Michael
    ANNALS OF HEMATOLOGY, 2021, 100 (08) : 2087 - 2093
12345